Straumann shares fall over 4% on sales, profit misses despite growth beat

Published 13/08/2025, 07:06
Updated 13/08/2025, 09:40
© Reuters

Investing.com -- Straumann Holding AG (SIX:STMN) shares fell more than 4% on Wednesday after the Swiss dental implant maker reported second-quarter and first-half results that missed consensus estimates for sales, EBIT and earnings per share, despite organic growth slightly topping forecasts.

First-half 2025 sales totaled 1.35 billion Swiss francs ($1.54 billion), 1% below consensus, while organic growth reached 10.2%, slightly above expectations. 

Core EBIT was 358 million francs, 2% under consensus, for a margin of 26.6%. Earnings per share missed by 8%, with the company citing higher interest costs tied to foreign exchange losses.

North America posted 2.7% organic growth in the second quarter, above the 2.2% consensus, with stable patient flow in the United States, Barclays (LON:BARC) said. 

Europe, the Middle East and Africa delivered 9.1% organic growth in the first half, aided by affordability, a multi-brand strategy and favorable geographic and product mix, according to Jefferies.

Asia Pacific sales were 1% below consensus, though organic growth was 19.6%. China is expected to remain a major growth driver, with 2025 organic growth of 10% to 15% seen as reasonable, Jefferies said. 

Latin America outperformed with 16.2% growth in the quarter, driven by the Neodent brand, Barclays said.

Straumann confirmed its 2025 guidance for high-single-digit organic revenue growth and a 30- to 60-basis-point improvement in core EBIT margin at constant 2024 currency rates. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.